↓ Skip to main content

Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella

Overview of attention for article published in Journal of Immune Based Therapies and Vaccines, January 2009
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella
Published in
Journal of Immune Based Therapies and Vaccines, January 2009
DOI 10.1186/1476-8518-7-1
Pubmed ID
Authors

Jerome S Harms, Marina A Durward, Diogo M Magnani, Gary A Splitter

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Spain 1 2%
Unknown 41 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 32%
Student > Ph. D. Student 9 20%
Student > Bachelor 4 9%
Student > Postgraduate 3 7%
Student > Master 2 5%
Other 5 11%
Unknown 7 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 19 43%
Biochemistry, Genetics and Molecular Biology 4 9%
Immunology and Microbiology 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Medicine and Dentistry 2 5%
Other 6 14%
Unknown 8 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2013.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Journal of Immune Based Therapies and Vaccines
#15
of 32 outputs
Outputs of similar age
#52,673
of 183,198 outputs
Outputs of similar age from Journal of Immune Based Therapies and Vaccines
#1
of 1 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.1. This one scored the same or higher as 17 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,198 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them